本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Arcutis Biotherapeutics Inc.

15.90
+0.89005.93%
盤後15.87-0.0300-0.19%19:59 EDT
成交量:197.55萬
成交額:3,099.96萬
市值:18.95億
市盈率:-15.29
高:15.93
開:14.98
低:14.92
收:15.01
資料載入中...
2022/02/22

重要事件披露

8-K - Current report
2022/02/22

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/22

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/23

重要事件披露

8-K - Current report
2021/12/15

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/09

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/07

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/07

持股變動聲明

3/A [Amend] - Initial statement of beneficial ownership of securities
2021/10/05

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/05

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/09/07

重要事件披露

8-K - Current report
2021/08/05

重要事件披露

8-K - Current report
2021/08/05

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/06/14

重要事件披露

8-K - Current report
2021/05/12

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/05/06

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/04

重要事件披露

8-K - Current report
2021/04/23

SEC問詢函

CORRESP [Cover] - Correspondence